- With the launch of the EU version of the "Starlink" competitor, Eutelsat expects revenue to reach 11 billions dollars.
- Chevron returns to exploring oil and gas in remote areas
- Société Générale Completes EUR 1.5 Billion Extraordinary Share Buyback
- Rubean Plans Private Placement of Up to 500,000 Shares at EUR 4.50 Each
- Vitro Announces Extraordinary Shareholders Meeting
- Manitou BF Announces Availability of Q3 2026 Revenue Release
- Manitou Confirms 2026 Revenue Growth Outlook of 6.5%-8.0%
- Montega Cuts TAKKT Price Target to EUR 3.50 From EUR 4.00
- Hopscotch Groupe Announces Availability of 2026 Half-Year Financial Report
- Montega Cuts Bertrandt Price Target to EUR 17 From EUR 18
- NX Filtration Presents Four-Engine Growth Strategy in Company Presentation
- Net Insight Publishes Q3 2026 Earnings Call Transcript
- RocTool Announces Availability of First-Half 2026 Financial Report
- PharmaMar First Nine Months 2026 Net Income Falls 43% to €8.7 Million
- Net Insight Publishes Q3 2026 Report
- Pharma Mar Names Elena Calleja Crespo CFO Effective Jan. 1, 2027
- AXA Expects 2026 Underlying EPS Growth at Top End of Target Range
- Imerys Announces Availability of Q3 2026 Results Release
- Figeac Aéro Reaffirms All Financial Targets
- Palantir Seen Beating Revenue Estimates, Raising Guidance, Oppenheimer Says
- Oxford Bank Q3 2026 net income attributable to parent rises 24% year over year to $3.79 million
- Universal Music Group Q3 2026 adjusted EBITDA rises 10% to EUR 729 million
- Sogefi Executive Beatrice De Minicis Sells Ordinary Shares for EUR 14,040
- Median Technologies H1 2026 net loss more than doubles year over year to €26.94 million
- Universal Music 3Q Adj EBITDA Margin 21.5%
- Analysts Had Forecast Universal Music 3Q Adj EBITDA of EUR692.5M
- Universal Music 3Q Adj EBITDA EUR729M
- Eutelsat Reaffirms FY 2026-27 Outlook for Slight Growth in Operating Verticals Revenue
- BUZZ - Sprouts shares fall after the company lowers its annual sales growth forecast
- Analysts Had Forecast Universal Music 3Q Rev of EUR3.33B
- BRIEF-Oxford Bank Q3 EPS USD 1.52
- ServiceNow Investors Seek Proof of AI Monetization After Q3 Results, RBC Says
- Von der Leyen Repeats 'Associate Member' Plan as EU-Canada to Discuss Closer Ties
- Amundi cuts total voting rights in flatexDEGIRO to 3.03% from 3.49%
- Table-Non-competitive bids for U.S. 7-year notes
- FIGS Positioned for Sustained Growth Across Products, Markets, Oppenheimer Says
- Person Associated With Intred Board Member Adalberto Salvi Buys Ordinary Shares for EUR 1,740
- Connection Capital says UK Budget offers investors respite, not major growth incentive
- High Quality Food Q3 Consolidated Revenue Rises 4% to EUR 4.67 Million
- Fairchild Gold Closes Non-Brokered Private Placement Financing Raising CA$725,200
- Nextpower Laying Groundwork for Growth, RBC Says
- Global Dominion Access Publishes Nine-Month 2026 Results Report
- BUZZ - Glaukos hits record high after unexpected profit announcement
- X-FAB Q3 2026 EBIT drops 82% year-on-year to USD 4.34 million
- Moody's affirms KRUK's Ba1 rating with stable outlook
- Global Dominion Access Nine-Month Attributable Net Profit Rises 35% to €8.2 Million
- Vertiv Posted Strong Q3 Results, Addressing Investor Concerns Over Execution Risk, Market Share, RBC Says
- Ford Motor Story to Improve Starting 2028 as New Businesses Contribute, RBC Capital Markets Says
- Entrecampos Cuatro Awaits Court Ruling in EUR 63.8 Million Tax Dispute
- BRIEF-Nav Canada In September 2026 Weighted Charging Units Were Higher On Average By 3.1 Percent
- --Perrigo Keeps Quarterly Dividend at $0.29 per Share, Payable Dec. 15 to Holders of Record Nov. 27
- Alphabet Shares Head for a Death Cross -- WSJ
- NASDAQ TRADE HALT <GBC.O> VOLATILITY TRADING PAUSE AT 12:34 PM
- Chevron Is Back to Searching for Oil and Gas in Far-Flung Places -- WSJ
- Eli Lilly's strong performance in its anti-obesity drug drives stock price to a record high, with Wall Street sentiment optimistic
- Google's Search Slowdown Seen Pressuring Shares Near-Term -- Market Talk
- Banco del Bajío keeps operating expense growth at or below guidance for fifth straight quarter
- BUZZ-Crocs shares surge after raising earnings outlook, third quarter results exceed expectations
- US Stock Movement: Karman Holdings surged on October 29 driven by forecasted financial growth, NASA Mars parachute project, and THAAD orders
- Walmart Launches Walmart+ Membership Program in Mexico
- Synsam publishes update to financial calendar
- Morgan Stanley cuts total voting rights in PVA TePla to 9.75% from 10.42%
- Perrigo Announces Quarterly Dividend of $0.29 Per Share
- Tecnotree Converts EUR 100,000 Debt Into 16,566 New Shares
- Dow Jones 12:30 PM Averages
- NASDAQ TRADE HALT <UCAR.O> VOLATILITY TRADING PAUSE AT 12:29 PM
- Medline to Remove or Correct All Branded Beds, Accessories Over Safety Risks, FDA Says
- Dominion Names Germán Pradera CEO Effective Jan. 1, 2027
- Mid America Apartment Communities Publishes Q3 2026 Earnings Call Transcript
- Caterpillar Shares Down, but Generator Order Backlog Stretches for Years -- WSJ
- Northern Minerals & Exploration delays annual report filing for fiscal 2026
- Cloudastructure Founder Sheldon Richard Bentley Reports Sale of $3,405 in Common Shares
- PEPE surged over 11% in 24 hours, reaching a high of 0.00000568 USDT.
- RheinErden Reports Overindebtedness With CHF 365,000 Shortfall
- Dynamix Enters Liquidation After Failing to Complete Business Combination
- Top Midday Stories: Alphabet Q3 EPS, Revenue Miss Targets; Caterpillar Shares Fall After Q3 Revenue Miss, Tepid Guidance
- Freegold Aims to Complete Updated Resource Estimate in Q2 2027 For Gold Summit Project in Alaska
- Vista Energy Raises 2026-2028 Cumulative Free Cash Flow Outlook to USD 2.8 Billion
- Crocs 3Q EPS $4.52 >CROX
- Builders FirstSource 3Q Sales $3.85B >BLDR
- Incyte 3Q Loss/Shr $3.86 >INCY
- Incyte 3Q Adj Loss/Shr $3.60 >INCY
- Incyte 3Q Loss $784.8M >INCY
- Incyte 3Q Rev $1.56B >INCY
- Phathom Pharmaceuticals 3Q Loss/Shr 16c >PHAT
- Oshkosh 3Q EPS $2.22 >OSK
- Oshkosh 3Q Adj EPS $2.41 >OSK
- Oshkosh 3Q Sales $2.84B >OSK
- Ligand Pharmaceuticals 3Q Loss/Shr $1.43 >LGND
- Ligand Pharmaceuticals 3Q Adj EPS $2.67 >LGND
- Ligand Pharmaceuticals 3Q Loss $28.5M >LGND
- Perella Weinberg Partners 3Q EPS 21c >PWP
- Crocs 3Q Net $216.8M >CROX
- Insmed 3Q Loss $100.3M >INSM
- Donnelley Fincl Solutions 3Q Adj EPS $1.07 >DFIN
- Donnelley Fincl Solutions 3Q Net $21.3M >DFIN
- Donnelley Fincl Solutions 3Q Sales $185M >DFIN
- Clorox Appoints Fabian Garcia As CEO >CLX
- Perella Weinberg Partners 3Q Rev $251.4M >PWP
- Builders FirstSource 3Q Adj EPS $1.51 >BLDR
